Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.3 CHF | +0.81% | +3.77% | +45.97% |
03/06 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
26/04 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.97% | 131.62Cr | |
+48.79% | 78TCr | |
+41.76% | 63TCr | |
+19.43% | 33TCr | |
+7.18% | 30TCr | |
+17.60% | 24TCr | |
-0.41% | 22TCr | |
+11.54% | 21TCr | |
+4.53% | 16TCr | |
-3.92% | 16TCr |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Licenses Topical Acne Medication to Hyundai Pharmaceuticals in South Korea